Blocking “don't eat me” signal of CD47-SIRPα in hematological malignancies, an in-depth review

Atlantis Dawn Russ(University of Arizona), Faiz Anwer(Cleveland Clinic), Irbaz Bin Riaz(Mayo Clinic), Jennifer S. Carew(University of Arizona), Anh Hua(University of Arizona), Steffan T. Nawrocki(University of Arizona), Daniel O. Persky(Universidad San Carlos), Bushra Rahman(University of Arizona), Muhammad Umar Khalid(University of Arizona), W.R. Montfort(University of Arizona)
Blood Reviews
April 14, 2018
10.1016/j.blre.2018.04.005
Cited by 192

Related Papers

Survivin: Key Regulator of Mitosis and Apoptosis and Novel Target for Cancer Therapeutics
|Clinical Cancer Research|2008|782
Targeting autophagy augments the anticancer activity of the histone deacetylase inhibitor SAHA to overcome Bcr-Abl–mediated drug resistance
|Blood|2007|485
Histone deacetylase inhibitors: Mechanisms of cell death and promise in combination cancer therapy
|Cancer Letters|2008|426
Bortezomib Inhibits PKR-Like Endoplasmic Reticulum (ER) Kinase and Induces Apoptosis via ER Stress in Human Pancreatic Cancer Cells
|Cancer Research|2005|324
Targeting HSP90 for cancer therapy
|British Journal of Cancer|2009|320